IMM-H-013

N/A

Report date: 2023/09/12 10:50:47
NME

Base Information

Drug NameIMM-H-013
Drug Alias NameIMM-H-013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsToll like receptor 4 antagonists
TargetsNuclear factor NF-kappa-B complexToll like receptor 4
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A